Atlas Trials

Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer

Clinical trial NCT06876636 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06876636
Sponsor
Xijing Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer Metastatic
Start date
2025-03-10
Primary completion
2025-12-01
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.